ArticleJournal of experimental & clinical cancer research : CR2022

A novel dual epigenetic approach targeting BET proteins and HDACs in Group 3 (MYC-driven) Medulloblastoma.

Matthew J Kling et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.